Anaphylaxis Campaign

Supporting people at risk of severe allergies

DonateEMERGENCY INSTRUCTIONS

Explore our Website

Access our Knowledgebase
The Knowledgebase is an online resource where you can search for information about allergy.
Information for Newly Diagnosed
Around one third of the UK population (approximately 19 million people) will develop an allergy at some time in their lives.
Fundraise
From marathons to wigs, everyone can fundraise!
Events
Find out what's going on near you.
Membership
Join us as a member of the Anaphylaxis Campaign today and help us to raise the profile of severe allergy and support those who live with life threatening allergies.
AllergyWise
AllergyWise is our online e-learning website with a selection of courses for you to learn about anaphylaxis, the risks of severe allergies and how to manage them.

Topics of Interest

Managing Allergens in the Workplace

We have developed a comprehensive guide for employees and employers to help people with severe allergies at work, including an adult allergy action plan. Read more…

Support Group Events

Our Support Groups are organised by our friendly volunteers, and are the perfect chance to meet other people living with severe allergies in your local area. Read more…

Making Schools Safer

Every school is likely to have at least one pupil who is severely allergic to a type of food, and many schools will have more. Read more…

News

Covid-19 vaccine passports: concerns from an allergy perspective

8th April 2021

As the Covid-19 vaccine roll-out continues apace in the UK, increasingly publicity has been given to the proposal that some form of certificate or ‘passport’ may be implemented, linked to the identity of the holder, to verify vaccination status and allow access to public venues, large gatherings, travel and other public arenas thereby, in theory, […]

Read More...

The Food Standards Agency Food Hypersensitivity Symposium

6th April 2021

On the 23rd and 24th March, the Food Standards Agency (FSA) held their second annual Food Hypersensitivity Symposium which brought together delegates from a variety of backgrounds including food business operators, local authority enforcement, clinical allergy specialists and allergy patient organisations.  The Anaphylaxis Campaign was delighted to attend and to contribute to the interactive workshops […]

Read More...

JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the COVID-19 vaccine

29th March 2021

The Joint Committee on Vaccination and Immunisation (JCVI) has advised the government to prioritise people for the coronavirus (COVID-19) vaccine who are over 16 and living with adults who have weakened immune systems, such as those with blood cancer, HIV or those on immunosuppressive treatment including chemotherapy. Adults who are immunosuppressed have a weaker immune […]

Read More...

Camallergy Ltd has been awarded 1.1M in funding for novel peanut allergy treatment

10th March 2021

Camallergy (Cambridge Allergy Ltd) a biopharmaceutical company dedicated to providing  innovative, patient-centric treatments for life-threatening food allergies, has announced it’s been awarded £1.1M funding under the Innovate UK Biomedical Catalyst Award program administered by Innovate UK, the United Kingdom’s research and innovation agency. It is hoped that the funding will accelerate the development of the peanut […]

Read More...